Slovak Conference at Bratislava Castle Joins the Transparency4Safety Initiative. Experts Call for Immediate Measures to Protect Public Health and a Reassessment of the Safety of mRNA Vaccines
Bratislava, 15 November 2026
The Civic Association for a Healthy and Just Society, building on the conclusions of the expert conference “To Vaccinate or Not to Vaccinate Against COVID-19?”, which it organised under the professional patronage of Prof. MUDr. Viliam Fischer, CSc., FICS, on 5 May 2026 at Bratislava Castle, hereby reaffirms its support for the international Transparency4Safety initiative, which seeks a transparent review of the safety of mRNA vaccines and the protection of the health of European citizens.
The conference at Bratislava Castle brought together Slovak and international experts in medicine, pharmacy, molecular biology and law. The speakers included Professor Viliam Fischer, Professor Štefan Hrušovský, Professor Jaroslav Turánek, RNDr. Tomáš Fürst, MUDr. Peter Lipták, MUDr. Martin Jančuška, Professor Jan Žaloudík, MUDr. Margaréta Černáková and MUDr. Soňa Peková.
JUDr. Marica Pirošíková, PhD., a member of our civic association, who has been working closely for a long time with Dr. Silvia Behrendt, a representative of the international Transparency4Safety initiative, also served on the organising committee of the Bratislava conference. This cooperation establishes an important link between the Slovak expert initiative and the broader European effort to review the safety of mRNA technologies.
Through its conclusions, the Slovak conference joined this initiative and addressed an open letter to the European Medicines Agency (EMA). In the letter, the experts highlighted the need to examine residual DNA, manufacturing processes, differences between manufacturing batches, toxicological data and the quality of pharmacovigilance records. They also called for an expert discussion with the responsible representatives of the EMA and for access to the data necessary to assess the safety of these products.
Our initiative is therefore not an isolated Slovak voice. It forms part of a broader European effort to protect citizens‘ health, ensure transparency in decision-making and consistently apply the precautionary principle.
Similar demands were recently formulated at the international Transparency4Safety conference, “Protecting European Citizens”, held on 21 October 2026 in Strasbourg under the auspices of the Patriots for Europe Foundation. The conference brought together scientists, doctors and legal experts from several countries.
The conference presented serious findings concerning the composition and biological effects of mRNA vaccines themselves. The speakers drew attention to residual and fragmented DNA, SV40 sequence elements, lipid nanoparticles, differences between manufacturing batches and insufficiently clarified questions concerning toxicological safety. Particularly concerning were the findings presented regarding the presence of DNA fragments and questions about their biological significance in products formulated using lipid nanoparticles.
Kevin McKernan presented analyses of residual and fragmented DNA, including SV40 promoter/enhancer sequences, and highlighted possible limitations of the analytical and regulatory testing methods currently in use. Professor Klaus Steger addressed cellular mechanisms of protein production, immunological mechanisms of potential harm and questions concerning residual DNA. Professor Andreas Schnepf highlighted the characterisation of lipid nanoparticles and differences in the quality and content of intact mRNA across individual manufacturing batches.
Dr. Helmut Sterz raised serious questions about the adequacy of toxicological studies, reproductive toxicity and possible long-term consequences. Dr. Michael Mörz presented pathological findings and discussed the importance of tissue examinations in investigating possible injuries following vaccination. Jonathan Gilthorpe addressed safety signals and observations relating to individual manufacturing batches.
The presentations concerning pharmacovigilance were also particularly alarming. Franziska Meyer-Hesselbarth drew attention to problems in recording and processing serious suspected adverse reactions. Wouter Aukema highlighted questions concerning the classification of the severity of reported events. If serious health events are recorded with delays or incorrectly classified, this may result in safety signals being overlooked and patients receiving inadequate protection.
The civic association points out that these questions cannot be separated from the legal proceedings taking place in the United States of America. Particular attention should be paid to the lawsuit filed by the State of Kansas against Pfizer in June 2024 by Attorney General Kris Kobach.
In its lawsuit, the State of Kansas accuses Pfizer of having been aware of serious adverse events associated with its COVID-19 vaccine, including myocarditis, pericarditis, unsuccessful pregnancies and deaths, while nevertheless publicly presenting its product as safe and effective. The lawsuit alleges that Pfizer concealed this serious safety information from the public or failed to communicate it adequately. It also specifically addresses claims concerning the safety of the vaccine for pregnant women.
The Kansas lawsuit also challenges Pfizer’s claims regarding the vaccine’s effectiveness against individual virus variants and its ability to prevent the transmission of infection between people. These are extremely serious allegations, because protecting others and preventing the spread of infection were repeatedly cited as reasons for vaccinating the public.
Similar issues are raised in the lawsuit filed by the State of Texas against Pfizer in November 2023, which alleged misleading communication about the effectiveness of the COVID-19 vaccine, particularly the presentation of 95% efficacy without disclosing the absolute risk reduction, which was approximately 0.84 percentage points. Texas also alleged inadequate disclosure of the gradual waning of protection and the presentation of the vaccine as a means of protecting others against infection, despite this ability not having been tested in the original clinical trial. The lawsuit also included allegations of suppressing critical public discussion.
In October 2026, Florida also joined the legal action by filing a lawsuit against Pfizer and its Chief Executive Officer, Albert Bourla. The lawsuit alleges misleading communication concerning the safety and effectiveness of the vaccine, inadequate disclosure of adverse effects, including myocarditis and pericarditis, as well as claims about protecting others against the transmission of infection, despite this ability not having been directly assessed in the original clinical trial. Florida also alleges unfair business practices and seeks judicial and financial remedies.
These legal actions constitute serious allegations brought by public authorities and raise questions concerning not only one manufacturer, but also the credibility of the pharmaceutical industry and the regulatory system. Their substance cannot be dismissed as an insignificant controversy.
We consider it particularly serious that questions concerning safety, the disclosure of risks and the actual ability of vaccines to prevent the transmission of infection have become central to legal proceedings in several US states. The public has the right to know what information manufacturers had available, how they communicated it and on what data decisions concerning mass vaccination of the population were based.
The EMA, meanwhile, continues to consider the benefit-risk balance of the Comirnaty vaccine to be positive. For this very reason, it is essential that the Agency provide specific answers to the questions raised by scientists and doctors. General assurances about safety cannot replace a transparent assessment of manufacturing, toxicological, clinical and pharmacovigilance data.
Following the meeting between the EMA and the Global Health Responsibility Agency (GHRA), which took place on 2 July 2026 in Amsterdam, the Agency stated in its summary report of 6 August 2026 that it had identified more than 3,000 documents for gradual disclosure. According to the organisers of the initiative, however, several specific scientific and regulatory questions remained unanswered in separate substantive responses.
We consider it unacceptable for serious safety concerns to be sidelined through administrative procedures and references to previous regulatory decisions. The public interest in protecting health must be duly taken into account both when deciding whether to disclose documentation and when assessing the continued use of these medicines.
The Civic Association for a Healthy and Just Society therefore calls on the Ministry of Health of the Slovak Republic, the State Institute for Drug Control, the EMA and the European Commission to undertake an independent reassessment of the safety of mRNA vaccines without delay, make the relevant regulatory documentation accessible, review the quality of pharmacovigilance data and publicly respond to the specific questions raised by experts.
We also demand that the precautionary principle be applied and that consideration be given without delay to suspending the relevant marketing authorisations for mRNA vaccines until fundamental safety questions have been resolved and their safe use has been ensured.
JUDr. Marica Pirošíková, PhD., a member of the Association for a Healthy and Just Society and a member of the organising committee of the Bratislava conference, states:
“The Strasbourg conference confirmed that questions concerning the safety of mRNA preparations can no longer be pushed to the margins of professional or public debate. The findings presented, the legal initiatives and the numerous unanswered questions provide serious grounds for immediate regulatory action. When human lives and health are at stake, the precautionary principle is not an option but an obligation. We reject an approach that waits for further harm to health instead of preventing risks. The EMA and the European Commission must assume their responsibility and act.”
JUDr. Erik Schmidt, Chairman of the Civic Association for a Healthy and Just Society, adds:
“The protection of human rights does not begin only after harm to health has already occurred. It begins with respect for every person’s right to life, health, dignity and informed consent. No institution, no manufacturer and no commercial interest can take precedence over these values. Where serious doubts exist concerning the safety of medicines administered for preventive purposes, national and European authorities have an obligation to act in the interests of citizens. Silence and inaction cannot be the answer to questions that concern human lives.”
The Association for a Healthy and Just Society hereby once again expresses its support for the Transparency4Safety initiative and its call for immediate regulatory action, including the suspension of the relevant marketing authorisations for mRNA vaccines while serious safety questions remain unresolved.
We call on Slovak and European representatives, doctors, scientists, lawyers, the media and the public to familiarise themselves with the materials presented, support transparency and demand specific answers from the responsible institutions.
The Association for a Healthy and Just Society (Za zdravú a spravodlivú spoločnosť, o. z.)
Website: https://www.bon-sens.sk/
Related documents and sources
- Bratislava conference “To Vaccinate or Not to Vaccinate Against COVID-19?”:
https://www.bon-sens.sk/ockovat-alebo-neockovat-proti-covid-19/ - Open letter from Czech and Slovak experts addressed to the EMA:
https://transparency4safety.substack.com/p/czech-and-slovak-professors-join - Transparency4Safety – Strasbourg conference:
https://transparency4safety.substack.com/
https://youtube.com/watch?v=qlJ1c1v0l2k&is=TSdZ_IwOxssAcaua - Kansas – lawsuit against Pfizer, June 2024:
https://www.ag.ks.gov/ - Texas – lawsuit against Pfizer, November 2023:
https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-sues-pfizer-misrepresenting-covid-19-vaccine-efficacy-and-conspiring - Florida – lawsuit against Pfizer and Albert Bourla, October 2026:
https://www.myfloridalegal.com/ - EMA – information on the safety of the Comirnaty vaccine:
https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty
Zdroj obr.: https://transparency4safety.substack.com/p/ema-time-to-act-and-stop-mrna-vaccines